ArticlePublisher preview available

Comparisons of the efficiency of respiratory rate monitoring devices and acoustic respiratory sound during endoscopic submucosal dissection

Authors:
To read the full-text of this research, you can request a copy directly from the authors.

Abstract and Figures

During moderate sedation for gastrointestinal endoscopic submucosal dissection (ESD), monitoring of ventilatory function is recommended. We compared the following techniques of respiratory rate (RR) measurement with respiratory sound (RRa): capnography (RRc), thoracic impedance (RRi), and plethysmograph (RRp). This study enrolled patients aged ≥ 20 years who underwent esophageal (n = 19) and colorectal (n = 5) ESDs. RRc, RRi, RRp, and RRa were measured by Capnostream™ 20P, BSM-2300, Nellcor™ PM1000N, and Radical-7®, respectively. In total, 413 RR data were collected from the esophageal ESD group and 114 RR data were collected from the colorectal ESD group. Compared with RRa during colorectal ESD, that during esophageal ESD had larger bias [95% limit of agreement (LOA)] with RRc [1.9 (− 11.0–14.8) vs. − 0.4 (− 2.9–2.2)], RRi [9.4 (− 16.8–9.4) vs. − 1.5 (− 12.0–8.9)], and RRp [0.3 (− 5.7–6.4) vs. 0.2 (− 3.2–3.6)]. Of the correct RR values displayed during esophageal ESD, > 90% were measured as RRa and RRp. Moreover, RRc was a useful parameter during colorectal ESD. To maximize patient safety during ESD under sedation, endoscopists and medical staff should know the feature and principle of the devices used for RR measurement. During esophageal ESD, RRa and RRp may be a good parameter to detect bradypnea or apnea. RRc, RRa and RRp are useful for reliable during colorectal ESD. Trial registration UMIN-CTR (UMIN000025421).
This content is subject to copyright. Terms and conditions apply.
Vol.:(0123456789)
1 3
Journal of Clinical Monitoring and Computing (2022) 36:1013–1019
https://doi.org/10.1007/s10877-021-00727-8
ORIGINAL RESEARCH
Comparisons oftheefficiency ofrespiratory rate monitoring devices
andacoustic respiratory sound duringendoscopic submucosal
dissection
TomokoFukada1 · YuriTsuchiya1· HirokoIwakiri1· MakotoOzaki1· MinoruNomura1
Received: 4 March 2021 / Accepted: 4 June 2021 / Published online: 12 June 2021
© The Author(s), under exclusive licence to Springer Nature B.V. 2021
Abstract
During moderate sedation for gastrointestinal endoscopic submucosal dissection (ESD), monitoring of ventilatory function is
recommended. We compared the following techniques of respiratory rate (RR) measurement with respiratory sound (RRa):
capnography (RRc), thoracic impedance (RRi), and plethysmograph (RRp). This study enrolled patients aged 20years who
underwent esophageal (n = 19) and colorectal (n = 5) ESDs. RRc, RRi, RRp, and RRa were measured by Capnostream™
20P, BSM-2300, Nellcor™ PM1000N, and Radical-7®, respectively. In total, 413 RR data were collected from the esopha-
geal ESD group and 114 RR data were collected from the colorectal ESD group. Compared with RRa during colorectal
ESD, that during esophageal ESD had larger bias [95% limit of agreement (LOA)] with RRc [1.9 (− 11.0–14.8) vs. 0.4
(− 2.9–2.2)], RRi [9.4 (− 16.8–9.4) vs. 1.5 (− 12.0–8.9)], and RRp [0.3 (− 5.7–6.4) vs. 0.2 (− 3.2–3.6)]. Of the correct RR
values displayed during esophageal ESD, > 90% were measured as RRa and RRp. Moreover, RRc was a useful parameter
during colorectal ESD. To maximize patient safety during ESD under sedation, endoscopists and medical staff should know
the feature and principle of the devices used for RR measurement. During esophageal ESD, RRa and RRp may be a good
parameter to detect bradypnea or apnea. RRc, RRa and RRp are useful for reliable during colorectal ESD.
Trial registration UMIN-CTR (UMIN000025421).
Keywords Endoscopic submucosal dissection· Respiratory rate· Capnography· Thoracic impedance· Plethysmograph·
Acoustic respiratory sound
1 Introduction
Gastrointestinal endoscopic submucosal dissection (ESD)
is usually performed under moderate sedation, using seda-
tives alone or in combination with analgesics or, sometimes,
using anesthetics such as propofol. Administration of these
drugs during ESD may sometimes induce deep sedation and
respiratory depression. The 2018 guidelines on moderate
procedural sedation and analgesia recommend continuous
capnometry monitoring of ventilatory function in addi-
tion to the standard monitoring by observation and pulse
oximetry unless precluded by the procedure or equipment
[1]. Pulse oximetry monitors oxygenation not ventilation,
whereas capnography detects hypoventilation before the
changes in pulse oximetry or respiratory rate (RR) under
oxygen supplement [2]. Therefore, capnography is the gold
standard of monitoring ventilatory function. However, RR
measured by capnography during upper gastrointestinal ESD
may be inaccurate because of the influence of insufflated
carbon oxide (CO2), which distends the intestinal lumen to
ensure adequate visibility and to secure the space required
for a safe procedure. On the other hand, RR measurement
by Radical-7®, which uses respiratory sound was reported
to be useful [3, 4]. Recently, various parameters are being
used to monitor RR at the operating room. The purpose of
this study was to determine and compare the utility of dif-
ferent RR monitoring devices during gastrointestinal ESD.
RR measured by Radical-7® (Masimo Japan Corp.,
Tokyo, Japan) with the use of acoustic respiratory sound
(RRa) was compared with RRs measured by capnography
(RRc) using Capnostream™ 20P (Medtronic Japan Co.,
* Tomoko Fukada
fukada.tomoko@twmu.ac.jp
1 Department ofAnesthesiology, School ofMedicine, Tokyo
Women’s Medical University, 8-1 Kawadacho Shinjukuku,
Tokyo162-8666, Japan
Content courtesy of Springer Nature, terms of use apply. Rights reserved.
... However, a new device (Nellcor ™ PM1000N, Medtronic Japan, Co. Ltd., Tokyo, Japan) that facilitates the concurrent measurement of the respiratory rate and percutaneous oxygen saturation is now available. The veracity of this device has been substantiated in cohorts undergoing low-flow oxygen therapy and in healthy individuals [3,[19][20][21]. However, the efficacy of Nellcor PM1000N (PM1000N) in gauging the respiratory rate in HFNC-utilizing patients remains unclear. ...
Article
Full-text available
Recently, the Nellcor PM1000N was developed for the concurrent assessment of respiratory rate and percutaneous oxygen saturation. However, the validation of respiratory rate measurements in patients receiving a high-flow nasal cannula (HFNC) using the PM1000N remains unestablished. Therefore, this study aimed to assess the validity of respiratory rate measurements obtained using PM1000N in patients receiving HFNC. A retrospective assessment was conducted on the respiratory rate measurements obtained using the PM1000N and electrocardiogram (ECG) impedance methods in comparison to those visually assessed by nurses. This evaluation included patients admitted to the Intensive Care Unit (ICU) of Sapporo Medical University Hospital who received HFNC between June 2022 and December 2022. Correlation coefficients, intraclass correlation coefficients (ICCs), Bland–Altman plots, and t-tests were employed to assess the concordance between the visually observed respiratory rates by nurses and those recorded by the PM1000N and ECG impedance. Twenty patients were enrolled in this study. Among them, 119 instances of respiratory rate were recorded. The ICCs for the PM1000N and impedance methods were 0.918 and 0.846, respectively, compared with the rates visually assessed by nurses. The mean differences were p = 0.947 (95% CI −3.186 to 0.2987) and p < .001 (95% CI 16.4609–17.9532), respectively. The PM1000N demonstrated superiority over ECG impedance in measuring respiratory rate in patients with HFNC. Furthermore, PM1000N shows promise for effective application in patients receiving HFNC.
... The veracity of this device has been substantiated in cohorts undergoing low-ow oxygen therapy and in healthy individuals (3,(19)(20)(21). However, the e cacy of Nellcor PM1000N (PM1000N) in gauging the respiratory rate in HFNC-utilizing patients remains unclear. ...
Preprint
Full-text available
Purpose: Recently, the Nellcor PM1000N was developed for the concurrent assessment of respiratory rate and percutaneous oxygen saturation. However, the validation of respiratory rate measurements in patients receiving a high-flow nasal cannula (HFNC) using the PM1000N remains unestablished. Therefore, this study aimed to assess the validity of respiratory rate measurements obtained using PM1000N in patients receiving HFNC. Methods: A retrospective assessment was conducted on the respiratory rate measurements obtained using the PM1000N and electrocardiogram (ECG) impedance methods in comparison to those visually assessed by nurses. This evaluation included patients admitted to the Intensive Care Unit (ICU) of Sapporo Medical University Hospital who received HFNC between June 2022 and December 2022. Correlation coefficients, intraclass correlation coefficients (ICCs), Bland-Altman plots, and t-tests were employed to assess the concordance between the visually observed respiratory rates by nurses and those recorded by the PM1000N and ECG impedance. Results: Twenty patients were enrolled in this study. Among them, 119 instances of respiratory rate were recorded. The ICCs for the PM1000N and impedance methods were 0.918 and 0.846, respectively, compared with the rates visually assessed by nurses. The mean differences were p=0.947 (95% CI: -3.186 – 0.2987) and p < .001 (95% CI: 16.4609–17.9532), respectively. Conclusion: The PM1000N demonstrated superiority over ECG impedance in measuring respiratory rate in patients with HFNC. Furthermore, PM1000N shows promise for effective application in patients receiving HFNC.
Article
Full-text available
Monitoring the patient's physiological functions is critical in clinical anesthesia. The latest version of the Japanese Society of Anesthesiologists' Guidelines for Safe Anesthesia Monitoring, revised in 2019, covers various factors, including electroencephalogram monitoring, oxygenation, ventilation, circulation, and muscle relaxation. However, with recent advances in monitoring technologies, the information provided has become more detailed, requiring practitioners to update their knowledge. At a symposium organized by the Journal of Anesthesia in 2023, experts across five fields discussed their respective topics: anesthesiologists need to interpret not only the values displayed on processed electroencephalogram monitors but also raw electroencephalogram data in the foreseeable future. In addition to the traditional concern of preventing hypoxemia, monitoring for potential hyperoxemia and the effects of mechanical ventilation itself will become increasingly important. The importance of using AI analytics to predict hypotension, assess nociception, and evaluate microcirculation may increase. With the recent increase in the availability of neuromuscular monitoring devices in Japan, it is important for anesthesiologists to become thoroughly familiar with the features of each device to ensure its effective use. There is a growing desire to develop and introduce a well-organized, integrated “single screen” monitor.
Article
We performed a systematic review and meta‐analysis to identify, classify and evaluate the body of evidence on novel wearable and contactless devices that measure heart rate, respiratory rate and oxygen saturations in the clinical setting. We included any studies of hospital inpatients, including sleep study clinics. Eighty‐four studies were included in the final review. There were 56 studies of wearable devices and 29 of contactless devices. One study assessed both types of device. A high risk of patient selection and rater bias was present in proportionally more studies assessing contactless devices compared with studies assessing wearable devices (p = 0.023 and p < 0.0001, respectively). There was high but equivalent likelihood of blinding bias between the two types of studies (p = 0.076). Wearable device studies were commercially available devices validated in acute clinical settings by clinical staff and had more real‐time data analysis (p = 0.04). Contactless devices were more experimental, and data were analysed post‐hoc. Pooled estimates of mean (95%CI) heart rate and respiratory rate bias in wearable devices were 1.25 (−0.31–2.82) beats.min‐1 (pooled 95% limits of agreement −9.36–10.08) and 0.68 (0.05–1.32) breaths.min‐1 (pooled 95% limits of agreement −5.65–6.85). The pooled estimate for mean (95%CI) heart rate and respiratory rate bias in contactless devices was 2.18 (3.31–7.66) beats.min‐1 (pooled limits of agreement −6.71–10.88) and 0.30 (−0.26–0.87) breaths.min‐1 (pooled 95% limits of agreement −3.94–4.29). Only two studies of wearable devices measured SpO2; these reported mean measurement biases of 3.54% (limits of agreement −5.65–11.45%) and 2.9% (−7.4–1.7%). Heterogeneity was observed across studies, but absent when devices were grouped by measurement modality and reference standard. We conclude that, while studies of wearable devices were of slightly better quality than contactless devices, in general all studies of novel devices were of low quality, with small (< 100) patient datasets, typically not blinded and often using inappropriate statistical techniques. Both types of devices were statistically equivalent in accuracy and precision, but wearable devices demonstrated less measurement bias and more precision at extreme vital signs. The statistical variability in precision and accuracy between studies is partially explained by differences in reference standards.
Article
A low-cost wearable pulse and respiratory monitoring system based on D-shaped single mode fiber (SMF) curvature sensor is proposed and investigated. The curvature sensing performance of D-shaped SMFs with different transmission loss are tested and analyzed, and the sensitivity up to -7.208%/m⁻¹. The D-shaped optical fiber structure is encapsulated by polydimethylsiloxane (PDMS) and implanted in a wrist strap, which realizes good wearability and comfort in the process of human pulse monitoring. The system adopts laser source module and signal acquisition module for integrated and miniaturized design, and real time signal acquisition using Field-Programmable Gate Array (FPGA). The real-time monitoring of pulse signal intensity and frequency before and after exercise was realized. The results show that pulse intensity increased after exercise, with a 10%-30% increase in pulse frequency, which is consistent with the results in medical theory. In addition, the D-shaped SMF encapsulated by PDMS also was implanted into the belt, which also successfully applied to the monitoring of respiratory signals under quiet and walking conditions.
Article
Full-text available
Previous studies documented the effectiveness and benefits of capnography monitoring during propofol-based sedation for colonoscopy to reduce the incidence of hypoxemia. However, the performance of capnography during longer duration endoscopic therapy of upper gastrointestinal tract cancers under CO2 insufflation it is not well known. In this study, we compare a new device with acoustic monitoring technology to standard capnography monitoring. We retrospectively analyzed 49 patients who underwent endoscopic resection of early upper gastrointestinal tract cancer between December 2013 and October 2014. All 49 patients were monitored using both acoustic monitoring technology and standard capnography. We investigated the duration of the periods with unmeasurable respiratory rate during the overall procedure. When comparing standard capnography monitoring to the new acoustic monitoring technology, the ratio of the unmeasurable time was significantly lower in RRa (36.9% vs. 21.6%, p < 0.01). The ratio of unmeasurable respiratory rate by capnography was strongly correlated to the ratio of unmeasurable PetCO2 level by capnography (R2 = 0.847). There were no severe events or adverse events (grade 2 or more) during all 49 procedures. The acoustic monitoring technology provides a more reliable respiratory monitoring when compared to standard capnography during endoscopic resection of upper gastrointestinal tract cancers under CO2 insufflation, even if the procedures were prolonged and complex.
Article
Full-text available
Gangliocytic paraganglioma (GP) has been regarded as a rare benign tumor that commonly arises from the second part of the duodenum. As GP does not exhibit either prominent mitotic activity or Ki-67 immunoreactivity, it is often misdiagnosed as neuroendocrine tumor (NET) G1. However, the prognosis might be better in patients with GP than in those with NET G1. Therefore, it is important to differentiate GP from NET G1. Moreover, our previous study indicated that GP accounts for a substantial, constant percentage of duodenal NETs. In the present article, we describe up-to-date data on the clinicopathological characteristics of GP and on the immunohistochemical findings that can help differentiate GP from NET G1, as largely revealed in our new and larger literature survey and recent multi-institutional retrospective study. Furthermore, we would like to refer to differential diagnosis and clinical management of this tumor and provide intriguing information about the risk factors for lymph node metastasis on GP.
Article
Full-text available
Aim . The study assessed the usefulness of a recently developed method for respiratory rate (RR) monitoring in patients undergoing endoscopic submucosal dissection (ESD) under deep sedation. Methods . Study subjects comprised 182 consecutive patients with esophageal cancer or gastric cancer undergoing ESD. The usefulness of acoustic RR monitoring was assessed by retrospectively reviewing the patients’ records for age, gender, height, weight, past history, serum creatinine, RR before ESD, and total dose of sedative. Results . Respiratory suppression was present in 37.9% of (69/182) patients. Continuous monitoring of RR led to detection of respiratory suppression in all these patients. RR alone was decreased in 24 patients, whereas both RR and blood oxygen saturation were decreased in 45 patients. Univariate analysis showed female gender, height, weight, and RR before treatment to be significantly associated with respiratory suppression. Multivariate analysis showed RR before treatment to be the only significant independent predictor [odds ratio (OR) 0.83, 95% confidence interval (CI) 0.73–0.95, and P = 0.006 ] of respiratory suppression. Conclusion . In this study, the difference in RR before treatment between patients with and without respiratory suppression was subtle. Therefore, we suggest that acoustic RR monitoring should be considered in patients undergoing ESD under sedation to prevent serious respiratory complications.
Article
Full-text available
To compare the safety and efficacy of carbon dioxide (CO2) and air insufflation during gastric endoscopic submucosal dissection (ESD). This study involved 116 patients who underwent gastric ESD between January and December 2009. After eliminating 29 patients who fit the exclusion criteria, 87 patients, without known pulmonary dysfunction, were randomized into the CO2 insufflation (n = 36) or air insufflation (n = 51) groups. Standard ESD was performed with a CO2 regulation unit (constant rate of 1.4 L/min) used for patients undergoing CO2 insufflation. Patients received diazepam for conscious sedation and pentazocine for analgesia. Transcutaneous CO2 tension (PtcCO2) was recorded 15 min before, during, and after ESD with insufflation. PtcCO2, the correlation between PtcCO2 and procedure time, and ESD-related complications were compared between the two groups. Arterial blood gases were analyzed after ESD in the first 30 patients (12 with CO2 and 18 with air insufflation) to assess the correlation between arterial blood CO2 partial pressure (PaCO2) and PtcCO2. There were no differences in respiratory functions, median sedative doses, or median procedure times between the groups. Similarly, there was no significant difference in post-ESD blood gas parameters, including PaCO2, between the CO2 and air groups (44.6 mmHg vs 45 mmHg). Both groups demonstrated median pH values of 7.36, and none of the patients exhibited acidemia. No significant differences were observed between the CO2 and air groups with respect to baseline PtcCO2 (39 mmHg vs 40 mmHg), peak PtcCO2 during ESD (52 mmHg vs 51 mmHg), or median PtcCO2 after ESD (50 mmHg vs 50 mmHg). There was a strong correlation between PaCO2 and PtcCO2 (r = 0.66; P < 0.001). The incidence of Mallory-Weiss tears was significantly lower with CO2 insufflation than with air insufflation (0% vs 15.6%, P = 0.013). CO2 insufflation did not cause any adverse events, such as CO2 narcosis or gas embolisms. CO2 insufflation during gastric ESD results in similar blood gas levels as air insufflation, and also reduces the incidence of Mallory-Weiss tears.
Article
Full-text available
Respiratory rate is recognized as a clinically important parameter for monitoring respiratory status on the general care floor (GCF). Currently, intermittent manual assessment of respiratory rate is the standard of care on the GCF. This technique has several clinically-relevant shortcomings, including the following: (1) it is not a continuous measurement, (2) it is prone to observer error, and (3) it is inefficient for the clinical staff. We report here on an algorithm designed to meet clinical needs by providing respiratory rate through a standard pulse oximeter. Finger photoplethysmograms were collected from a cohort of 63 GCF patients monitored during free breathing over a 25-min period. These were processed using a novel in-house algorithm based on continuous wavelet-transform technology within an infrastructure incorporating confidence-based averaging and logical decision-making processes. The computed oximeter respiratory rates (RRoxi) were compared to an end-tidal CO2 reference rate (RRETCO2). RRETCO2 ranged from a lowest recorded value of 4.7 breaths per minute (brpm) to a highest value of 32.0 brpm. The mean respiratory rate was 16.3 brpm with standard deviation of 4.7 brpm. Excellent agreement was found between RRoxi and RRETCO2, with a mean difference of -0.48 brpm and standard deviation of 1.77 brpm. These data demonstrate that our novel respiratory rate algorithm is a potentially viable method of monitoring respiratory rate in GCF patients. This technology provides the means to facilitate continuous monitoring of respiratory rate, coupled with arterial oxygen saturation and pulse rate, using a single non-invasive sensor in low acuity settings.
Article
Background: Current methods for monitoring ventilatory rate have limitations including poor accuracy and precision and low patient tolerance. In this study, we evaluated a new acoustic ventilatory rate monitoring technology for accuracy, precision, reliability, and the ability to detect pauses in ventilation, relative to capnometry and a reference method in postsurgical patients. Methods: Adult patients presenting to the postanesthesia care unit were connected to a Pulse CO-Oximeter with acoustic monitoring technology (Rad-87, version 7804, Masimo, Irvine, CA) through an adhesive bioacoustic sensor (RAS-125, rev C) applied to the neck. Each subject also wore a nasal cannula connected to a bedside capnometer (Capnostream20, version 4.5, Oridion, Needham, MA). The acoustic monitor and capnometer were connected to a computer for continuous acoustic and expiratory carbon dioxide waveform recordings. Recordings were retrospectively analyzed by a trained technician in a setting that allowed for the simultaneous viewing of both waveforms while listening to the breathing sounds from the acoustic signal to determine inspiration and expiration reference markers within the ventilatory cycle without using the acoustic monitor- or capnometer-calculated ventilatory rate. This allowed the automatic calculation of a reference ventilatory rate for each device through a software program (TagEditor, Masimo). Accuracy (relative to the respective reference) and precision of each device were estimated and compared with each other. Sensitivity for detection of pauses in ventilation, defined as no inspiration or expiration activity in the reference ventilatory cycle for ≥30 seconds, was also determined. The devices were also evaluated for their reliability, i.e., the percentage of the time when each displayed a value and did not drop a measurement. Results: Thirty-three adults (73% female) with age of 45 ± 14 years and weight 117 ± 42 kg were enrolled. A total of 3712 minutes of monitoring time (average 112 minutes per subject) were analyzed across the 2 devices, reference ventilatory rates ranged from 1.9 to 49.1 bpm. Acoustic monitoring showed significantly greater accuracy (P = 0.0056) and precision (P- = 0.0024) for respiratory rate as compared with capnometry. On average, both devices displayed data over 97% of the monitored time. The (0.95, 0.95) lower tolerance limits for the acoustic monitor and capnometer were 94% and 84%, respectively. Acoustic monitoring was marginally more sensitive (P = 0.0461) to pauses in ventilation (81% vs 62%) in 21 apneic events. Conclusions: In this study of a population of postsurgical patients, the acoustic monitor and capnometer both reliably monitored ventilatory rate. The acoustic monitor was statistically more accurate and more precise than the capnometer, but differences in performance were modest. It is not known whether the observed differences are clinically significant. The acoustic monitor was more sensitive to detecting pauses in ventilation. Acoustic monitoring may provide an effective and convenient means of monitoring ventilatory rate in postsurgical patients.
Article
The use of carbon dioxide (CO(2)) insufflation during endoscopic procedures is effective in reducing patient discomfort caused by bloating. However, transcutaneous arterial CO(2) (PtCO(2)) monitoring usually is required for safety during long endoscopic procedures. To evaluate a new capnometer for monitoring end-tidal carbon dioxide (EtCO(2)) concentrations and to compare PtCO(2) with EtCO(2) measured in the same patient, a prospective comparative study of EtCO(2) and PtCO(2) values measured simultaneously was designed. The study enrolled 20 consecutive patients (18 men and two women; mean age, 70.1 years) with upper gastrointestinal neoplasms scheduled for endoscopic submucosal dissection (ESD) using conscious sedation with CO(2) insufflation, and EtCO(2) and PtCO(2) were simultaneously measured by each capnometer. Patient status was evaluated before ESD by the American Society of Anesthesiologists (ASA) physical status classification system, and eight patients were judged as class 1, nine patients as class 2, and three patients as class 3. The exclusion criteria ruled out patients with chronic obstructive pulmonary disease or ASA class 4 or 5 physical status. The correlation between EtCO(2) and PtCO(2) values and the availability of EtCO(2) capnography were investigated. The mean EtCO(2) value during ESD was 34.7 ± 4.5 mmHg, and the mean PtCO(2) value was 51.6 ± 2.4 mmHg. There was a statistically significant correlation between EtCO(2) and PtCO(2) (r = 0.331; P = 0.002). Hypoxic events (<90% oxygen saturation [SpO(2)]) caused by decreased respiratory rate occurred for 12 patients. In 10 (83%) of 12 events, a significant reduction in EtCO(2) was seen before the decrease in SpO(2). The EtCO(2) values correlated with the PtCO(2) values, and the respiratory monitoring methods allowed earlier detection of hypoxia during ESD with conscious sedation than transcutaneous monitoring. The EtCO(2) capnometer was considered to be available for the ESD procedure with the patient under conscious sedation using CO(2) insufflation.
Article
It is well known that carbon dioxide (CO(2)) is absorbed faster in the body than air and also that it is rapidly excreted through respiration. This study aimed to investigate the safety of CO(2) insufflation used for esophageal and gastric endoscopic submucosal dissection (ESD) in patients under deep sedation. Patients with either early gastric or esophageal cancers that could be resected by ESD were enrolled in this study from March 2007 to July 2008 and randomly assigned to undergo ESD procedures with CO(2) insufflation (CO(2) group) or air insufflation (air group). A TOSCA measurement system and TOSCA 500 monitor were used to measure and monitor both transcutaneous partial pressure of CO(2) (PtcCO(2)) and oxygen saturation (SpO(2)). The study enrolled 89 patients and randomly assigned them to a CO(2) group (45 patients) or an air group (44 patients). The mean CO(2) group versus air group measurements were as follows: PtcCO(2) (49.1 +/- 5.0 vs. 50.1 +/- 5.3 mmHg; nonsignificant difference [NS]), maximum PtcCO(2) (55.1 +/- 6.5 vs. 56.8 +/- 7.0 mmHg; NS), PtcCO(2) elevation (9.1 +/- 5.4 vs. 11.4 +/- 5.6 mmHg; p = 0.054), SpO(2) (99.0 +/- 0.7% vs. 99.0 +/- 1.0%; NS), minimum SpO(2) (96.5 +/- 2.4% vs. 95.4 +/- 3.3%; p = 0.085), and SpO(2) depression (2.4 +/- 2.3% vs. 3.3 +/- 2.9%; NS). The PtcCO(2) and SpO(2) measurements were similar in the two groups, but the CO(2) group was better than the air group in PtcCO(2) elevation and minimum SpO(2). The findings demonstrated CO(2) insufflation to be as safe as air insufflation for upper gastrointestinal tract ESDs performed for patients under deep sedation without evidencing any adverse effects.